Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
8080
Trial Sponsor
Trial Collaborator
Clinical Trial Start Date
April 24, 2020
0Primary Completion Date
March 23, 2021
0Study Completion Date
April 23, 2021
0Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Prospective0
Participating Facility
Official Name
ImmuneRACE - Immune Response Action to COVID-19 Events0
Last Updated
February 16, 2022
0Study summary
ImmuneRACE is a study, which is designed to better understand the immune response to COVID-19. This is critically important because the immune system may be able to tell us important information about how our own bodies detect and respond to the disease that current tests cannot. De-identified data collected from this study may accelerate the development of better diagnostics for COVID-19 and improve outcomes for many.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
